José Luis Molinuevo Selected Research

José Luis Molinuevo Research Topics

Disease

95	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 05/2002
45	Cognitive Dysfunction 06/2023 - 01/2014
41	Dementia (Dementias) 11/2023 - 07/2008
8	Atrophy 01/2021 - 05/2011
8	Parkinson Disease (Parkinson's Disease) 01/2020 - 03/2002
6	Neuroinflammatory Diseases 10/2022 - 03/2015
6	Disease Progression 12/2021 - 01/2016
6	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 07/2008
4	Gliosis 11/2022 - 01/2020
3	COVID-19 10/2022 - 01/2020
3	Inflammation (Inflammations) 01/2022 - 02/2016
3	Amyloid Plaque 01/2021 - 10/2018
3	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2014 - 07/2008
2	Neurobehavioral Manifestations 11/2023 - 01/2018
2	Prodromal Symptoms 01/2019 - 11/2014
2	Parkinsonian Disorders (Parkinsonism) 01/2015 - 03/2014
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 12/2023
1	Mood Disorders (Mood Disorder) 01/2023
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2023
1	Amyloidosis 01/2022
1	Body Weight Changes 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Genetic Risk Score 11/2020
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020
1	Death (Near-Death Experience) 06/2019
1	Down Syndrome (Down's Syndrome) 11/2017
1	Mental Disorders (Mental Disorder) 01/2017
1	Multiple Sclerosis 01/2017
1	Neoplasms (Cancer) 11/2016
1	Cerebral Cortical Thinning 02/2015
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 01/2014
1	Glioma (Gliomas) 01/2014
1	Communication Disorders (Communication Disorder) 01/2014
1	REM Sleep Behavior Disorder 01/2014
1	Autoimmune Diseases of the Nervous System 01/2014
1	Stroke (Strokes) 01/2014
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2014
1	Wernicke Aphasia (Receptive Aphasia) 01/2012
1	Corticobasal Degeneration 01/2012
1	Synucleinopathies 09/2011
1	Hepatic Encephalopathy 09/2011
1	Fibrosis (Cirrhosis) 09/2011
1	Frontotemporal Dementia (Semantic Dementia) 02/2010

Drug/Important Bio-Agent (IBA)

74	Biomarkers (Surrogate Marker)IBA 01/2024 - 02/2011
46	Amyloid (Amyloid Fibrils)IBA 11/2023 - 08/2003
18	Apolipoproteins E (ApoE)IBA 12/2023 - 05/2015
11	ApolipoproteinsIBA 01/2022 - 01/2017
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2003
6	flutemetamolIBA 10/2022 - 06/2019
4	Amyloid beta-PeptidesIBA 01/2022 - 01/2018
4	Indicators and Reagents (Reagents)IBA 10/2021 - 01/2018
3	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2023 - 01/2022
3	Glial Fibrillary Acidic ProteinIBA 11/2022 - 12/2021
3	Glucose (Dextrose)FDA LinkGeneric 11/2022 - 01/2021
3	Cholinesterase Inhibitors (Anticholinesterases)IBA 10/2021 - 01/2015
3	NeurograninIBA 01/2021 - 01/2021
3	Donepezil (Aricept)FDA LinkGeneric 01/2019 - 04/2013
3	Presenilin-1IBA 05/2011 - 05/2002
2	3- (3,5- dichlorophenyl)- 1- methyl- 2,5- pyrrolidinedione (DPMS)IBA 01/2023 - 01/2019
2	Memantine (Namenda)FDA Link 10/2021 - 01/2015
2	(2- (6- fluoro- 1H- indol- 3- yl)- ethyl)- (3- (2,2,3,3- tetrafluoropropoxy)benzyl)amineIBA 01/2019 - 01/2018
2	Peptides (Polypeptides)IBA 01/2019 - 01/2014
2	MicroRNAs (MicroRNA)IBA 11/2017 - 08/2014
2	SynucleinsIBA 02/2015 - 07/2008
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 03/2014 - 09/2011
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2022
1	Interleukin-6 (Interleukin 6)IBA 10/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2022
1	Antidepressive Agents (Antidepressants)IBA 10/2021
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2021
1	ChitinasesIBA 01/2020
1	CytokinesIBA 01/2020
1	Complement System Proteins (Complement)IBA 01/2019
1	Biocompatible Materials (Biomaterials)IBA 01/2019
1	LipidsIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Apolipoprotein E4IBA 01/2017
1	Air Pollutants (Pollutants, Air)IBA 01/2017
1	CarcinogensIBA 11/2016
1	Rivastigmine (Exelon)FDA LinkGeneric 01/2015
1	Galantamine (Galanthamine)FDA LinkGeneric 01/2015
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2014
1	Leucine (L-Leucine)FDA Link 01/2014
1	N-Methylaspartate (NMDA)IBA 01/2014
1	tau Proteins (tau Protein)IBA 01/2014
1	Cytochrome P-450 CYP2B1 (PROD)IBA 01/2014
1	Surface Antigens (Surface Antigen)IBA 01/2014
1	AntigensIBA 01/2014
1	AntibodiesIBA 01/2014
1	ProgranulinsIBA 01/2012
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2010
1	UbiquitinIBA 07/2008

Therapy/Procedure

6	Secondary Prevention 10/2020 - 02/2016
4	Therapeutics 01/2022 - 01/2018
2	Aftercare (After-Treatment) 04/2013 - 02/2010
1	Cognitive Training 01/2021
1	Hand Hygiene 01/2020
1	Intravenous Administration 06/2019
1	Activities of Daily Living (ADL) 01/2018
1	Liver Transplantation 09/2011